Search

everythinglearnresearchcommunity

for

Search:↓

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Ultrasound and Doppler analysis are valuable tools for diagnosing and understanding polycystic ovary syndrome.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

Fibroblast growth factors could be a better, safer treatment for hair loss than current options.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

PCOS and eating disorders are linked by hormonal imbalances, needing personalized treatment.

Fetal ovaries produce different hormones than adult ovaries, and endocrine-disrupting chemicals may affect this process.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Plant sterols have health benefits like lowering cholesterol, but more research is needed to understand their effects and improve their extraction and sustainability.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Innovative cosmetics could safely change hair color by targeting biological hair pigmentation processes.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

A woman's rare benign tumor that released both cortisol and testosterone was successfully removed, improving her health.

Recombinant collagen is promising for biomaterials, pharmaceuticals, and skincare due to its benefits and potential improvements.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Hair relaxers are linked to reduced cystine levels and potential hair damage.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.